
Seres Therapeutics, Inc.
USD5.25
+0.14 (+2.74%)
CEO
Richard N. Kender
IPO Date
2015-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.16
Prev. Close
$5.11
Day Low
$5.10
Day High
$5.33
52W Low
$5.00
52W High
$29.98
Market Cap
$0.05B
Volume
0.03M
| 20 Mar 2025 |
| Chardan Capital |
| Buy |
| Buy |
| maintain |
| 14 Mar 2025 | Goldman Sachs | Sell | Sell | maintain |
| 14 Nov 2024 | Canaccord Genuity | Buy | Buy | maintain |
| 13 Nov 2024 | Chardan Capital | Buy | Buy | maintain |
| 24 Oct 2024 | JP Morgan | Neutral | Underweight | downgrade |
| 13 Sept 2024 | Canaccord Genuity | Buy | Buy | maintain |
| 14 Aug 2024 | Chardan Capital | Buy | Buy | maintain |